Influence of age on prognosis of young patients with uveal melanoma: A matched retrospective cohort study

Swathi Kaliki, Carol L. Shields, Arman Mashayekhi, Anuradha Ganesh, Minoru Furuta, Jerry A. Shields

Research output: Contribution to journalArticle

23 Citations (Scopus)


Purpose. To determine the influence of patient age on life prognosis in patients with uveal melanoma. Design. Matched retrospective cohort study of 122 patients in each age category (young [≤20 years], mid-adults [21-60 years], older adults [>60 years]). Results. Kaplan-Meier estimates of tumor-related metastasis at 3, 5, and 10 years were 1%, 8%, and 8% in young; 8%, 11%, and 26% in mid-adults; and 13%, 16%, and 24% in older adults. After exclusion of iris melanoma, Kaplan-Meier estimates of tumor-related metastasis at 3, 5, and 10 years were 2%, 11%, and 18% in young; 9%, 14%, and 21% in mid-adults; and 9%, 34%, and 33% in older adults. Risk factors for metastasis based on multivariate analysis included increasing age in young (p=0.05, hazard ratio [HR] 1.33), male gender in mid-adults (p=0.046, HR 4.23), and larger tumor basal diameter in mid-adults (p=0.002, HR 1.37) and older adults (p=0.001, HR 1.30). After adjusting for tumor diameter, the metastatic rate was lower in young patients compared to mid-adults (0=0.042, HR 3.00) and older adults (p=0.007, HR 4.20). Conclusions. Younger patient age at the time of diagnosis of uveal melanoma is associated with lower rate of metastasis compared to mid-adults and older adults.

Original languageEnglish
Pages (from-to)208-216
Number of pages9
JournalEuropean Journal of Ophthalmology
Issue number2
Publication statusPublished - 2013



  • Children
  • Eye
  • Melanoma
  • Metastasis
  • Pediatric
  • Prognosis
  • Tumor
  • Uvea

ASJC Scopus subject areas

  • Ophthalmology

Cite this